1. Home
  2. WPC vs NBIX Comparison

WPC vs NBIX Comparison

Compare WPC & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo W. P. Carey Inc. REIT

WPC

W. P. Carey Inc. REIT

HOLD

Current Price

$66.31

Market Cap

16.5B

Sector

Real Estate

ML Signal

HOLD

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$144.27

Market Cap

15.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WPC
NBIX
Founded
1973
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.5B
15.5B
IPO Year
1998
1996

Fundamental Metrics

Financial Performance
Metric
WPC
NBIX
Price
$66.31
$144.27
Analyst Decision
Hold
Strong Buy
Analyst Count
9
22
Target Price
$73.11
$180.91
AVG Volume (30 Days)
1.1M
927.8K
Earning Date
04-28-2026
05-05-2026
Dividend Yield
5.11%
N/A
EPS Growth
N/A
41.95
EPS
1.33
3.30
Revenue
$1,716,485,000.00
$161,626,000.00
Revenue This Year
$6.59
$24.73
Revenue Next Year
$6.16
$13.14
P/E Ratio
$49.91
$44.30
Revenue Growth
8.43
977.51
52 Week Low
$63.08
$122.14
52 Week High
$77.22
$186.12

Technical Indicators

Market Signals
Indicator
WPC
NBIX
Relative Strength Index (RSI) 21.56 30.58
Support Level $63.47 $141.00
Resistance Level $74.90 $161.41
Average True Range (ATR) 1.10 4.33
MACD -0.35 -0.74
Stochastic Oscillator 2.30 1.21

Price Performance

Historical Comparison
WPC
NBIX

About WPC W. P. Carey Inc. REIT

W.P. Carey Inc is a real estate investment trust principally involved in the ownership of properties located in the U.S., Western Europe, and Northern Europe. W.P. Carey organizes its operations into Real Estate and Investment Management segments. The vast majority of the company's income is derived from its Real Estate division in the form of lease revenue from long-term agreements with companies. W.P. Carey's real estate portfolio is comprised of single-tenant office, industrial, warehouse, and retail facilities located around the world. majority of the company's revenue comes from properties in the USA. Its Investment Management unit generates revenue from providing real estate advisory and portfolio management services to other REITs.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

Share on Social Networks: